Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
First Advantage Corporation (FA)
Sprinklr, Inc. (CXM)
Coliseum Acquisition (MITAU)
Upcoming IPO
Soulgate Inc. (SSR)
Bright Health Group Inc. (BHG)
Doximity, Inc. (DOCS)
Miromatrix Medical, Inc (MIRO)
Confluent, Inc. (CFLT)
Monte Rosa Therapeutics Inc. (GLUE)
Amtd Digital, Inc. (HKD)
Unicycive Therapeutics Inc. (UNCY)
Acurx Pharmaceuticals (ACXP)
Mister Car Wash, Inc. (MCW)
Elevation Oncology, Inc. (ELEV)
Alpha Teknova, Inc. (TKNO)
Gh Research Plc (GHRS)
Graphite Bio, Inc. (GRPH)
The Glimpse Group (VRAR)
Integral Ad Science Holding Corp. (IAS)
D-MARKET Electronic Services & Trading (HEPS)
Missfresh Limited (MF)
Dingdong (cayman) Limited (DDL)
Xometry, Inc. (XMTR)
Sentinelone, Inc. (S)
Intapp, Inc. (INTA)
Cvrx, Inc. (CVRX)
Legalzoom.com, Inc. (LZ)
Clear Secure, Inc. (YOU)
Torrid Holdings, Inc. (CURV)
D-market Electronic Services & Trading (HBX)
Evercommerce Inc (EVCM)
Krispy Kreme, Inc. (DNUT)
Priced IPO
Full Truck Alliance Co. Ltd. (YMM)
Century Therapeutics, Inc (IPSC)
Atai Life Sciences B.v. (ATAI)
Femasys (FEMY)
Tremor International Ltd. (TRMR)
Cyteir Therapeutics, Inc. (CYT)
Codex Dna, Inc. (DNAY)
Aihuishou International Co. Ltd. (RERE)
Ambrx Biopharma Inc (AMAM)
iSpecimen (ISPC)
Angel Oak Mortgage, Inc. (AOMR)
Lyell Immunopharma, Inc. (LYEL)
Verve Therapeutics, Inc. (VERV)
Molecular Partners Inc. (MOLN)
Walkme Ltd. (WKME)
Convey Holding Parent, Inc. (CNVY)
Alzamend Neuro (ALZN)
Taskus, Inc. (TASK)
Janux Therapeutics, Inc. (JANX)
Kanzhun Limited (BZ)
More companies

Vera Therapeutics, Inc. (VERA)

Sector - Healthcare

Price chart

+38.18%
Return from IPO

Company News

IPO Profile

About company

Company Logo
They are a clinical stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Their lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. They are conducting a Phase 2b clinical trial of atacicept in patients with immunoglobulin A nephropathy (IgAN), a disease with a high unmet medical need and no approved therapies. As reported in a Phase 2a clinical trial of 16 patients conducted by Merck KGaA, Darmstadt, Germany, atacicept is the first and only molecule currently in development to demonstrate a 60% reduction in plasma Gd-IgA1 in IgAN patients (75 mg dose, n=4 at 24 weeks), which they believe can be disease modifying. They plan to initiate patient screening for their Phase 2b clinical trial in IgAN in the second quarter of 2021, and they expect to report topline results in the fourth quarter of 2022.
Industry
Pharmaceutical Preparations
CEO CFO
Marshall Fordyce Jonathan Wolter
Employees Founded
8 2016

Contacts

Address: 170 Harbor Way, 3rd Floor South San Francisco, California 94080

Telephone: (650) 770-0077

Web page: http://www.veratx.com

IPO information

First Trade Date 5/14/2021
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Shares & Volumes

Shares Initial (MM) 4.4
Shares Revised (MM) 4.35
Expected offer amount (MM) $65.25
Realized offer amount(MM) $47.85

Financial Data (last reporting year)

Market Cap (MM) $307.2
Revenues (MM) $0
Net Income (Loss) (MM) $-53.4

Voting

What do you think will happen with the VERA share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
The lead left underwriter: Jefferies

IPOs led by the firm .Pro
Profitability of conducted IPOs  ?  .Pro
1st day change  ?  .Pro
Change for the first 3 months  ?  .Pro
Underwriters
Jefferies/ Cowen/ Evercore ISI
CO-Managers
-

Sector: Healthcare

Tweets about $VERA

Tweets volume:

RT volume:

Timeframe:

Google Trends Stats